Michael Folkert, MD PhD DABR

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Augmenix, Inc. (now Boston Scientific, Inc.)
    Date added:
    Date updated:
    07/29/2021
  • Attribution:
    Self
    Type of financial relationship:
    Travel
    Ineligible company:
    Boston Scientific, Inc.
    Date added:
    Date updated:
    07/29/2021
Return to 158 Sarcoma DOT Case Conference (022221)

 

**Disclaimer**

This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.